VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 783 filers reported holding VANECK VECTORS ETF TR in Q4 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $2,173,661 | -14.6% | 64,063 | -20.4% | 2.48% | -23.7% |
Q1 2024 | $2,545,792 | -20.7% | 80,512 | -22.2% | 3.25% | -36.2% |
Q4 2023 | $3,210,919 | -14.4% | 103,544 | -25.7% | 5.10% | -18.8% |
Q3 2023 | $3,749,454 | -14.3% | 139,333 | -4.2% | 6.28% | +2.0% |
Q2 2023 | $4,377,636 | -8.4% | 145,388 | -1.6% | 6.16% | -16.0% |
Q1 2023 | $4,777,548 | +21.5% | 147,683 | +7.6% | 7.33% | +8.8% |
Q4 2022 | $3,933,101 | +15.0% | 137,233 | -3.2% | 6.74% | +14.8% |
Q3 2022 | $3,421,000 | +1.7% | 141,813 | +3.7% | 5.87% | +15.5% |
Q2 2022 | $3,363,000 | -44.2% | 136,743 | -12.9% | 5.08% | -17.5% |
Q1 2022 | $6,022,000 | -2.7% | 157,024 | -18.8% | 6.16% | -1.7% |
Q4 2021 | $6,192,000 | +5.0% | 193,324 | -3.4% | 6.26% | +10.4% |
Q3 2021 | $5,897,000 | -5.3% | 200,114 | +9.3% | 5.68% | -5.8% |
Q2 2021 | $6,224,000 | +13.1% | 183,154 | +8.1% | 6.03% | +2.2% |
Q1 2021 | $5,504,000 | +27.7% | 169,359 | +41.5% | 5.90% | +24.2% |
Q4 2020 | $4,311,000 | -7.6% | 119,679 | +0.4% | 4.74% | -26.1% |
Q3 2020 | $4,667,000 | -17.7% | 119,169 | -22.9% | 6.42% | -20.2% |
Q2 2020 | $5,672,000 | +62.8% | 154,634 | +2.2% | 8.05% | +6.4% |
Q1 2020 | $3,484,000 | -28.3% | 151,234 | -8.9% | 7.56% | +21.3% |
Q4 2019 | $4,860,000 | +14.4% | 165,980 | +4.3% | 6.24% | +6.3% |
Q3 2019 | $4,249,000 | -29.6% | 159,070 | -32.6% | 5.86% | -34.2% |
Q2 2019 | $6,033,000 | +42.5% | 236,020 | +25.0% | 8.92% | +61.4% |
Q1 2019 | $4,235,000 | +114.6% | 188,880 | +101.9% | 5.52% | -18.8% |
Q4 2018 | $1,973,000 | +84.6% | 93,550 | +103.4% | 6.81% | +578.6% |
Q4 2017 | $1,069,000 | -53.2% | 45,990 | -53.7% | 1.00% | -58.3% |
Q3 2017 | $2,282,000 | +74.6% | 99,380 | +73.4% | 2.41% | +89.2% |
Q1 2017 | $1,307,000 | -35.2% | 57,308 | -40.6% | 1.27% | -30.5% |
Q4 2016 | $2,017,000 | +85.2% | 96,430 | +134.0% | 1.83% | +68.4% |
Q3 2016 | $1,089,000 | -38.5% | 41,210 | -35.5% | 1.09% | -67.0% |
Q2 2016 | $1,772,000 | – | 63,940 | – | 3.29% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |